Basic Information
RNALocate ID: | RLID:11003896 |
RNA Symbol: | hsa-miR-340-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-340 |
RNA ID: | miRBase:MIMAT0004692 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 18589210 |
Tissue/Cell Line: | Serum |
Method: | Microarray |
Description: | Association of microRNA with peripheral blood-derived tumor exosomes compared with microRNA isolated from their corresponding tumors. Data are collected from Table 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002631 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11003895 | Exosome | Serum | 29143228 |
RLID:11003897 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11003898 | Exosome | Brain tissue | 23382797 |
RLID:11003899 | Exosome | Plasma | 23663360 |
RLID:11003900 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11003901 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11003902 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID-D:11000198 | Exosome | Blood|Breast milk|Endothelial cells|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000664 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-340-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-41928 |
MNDR | hsa-miR-340-5p | Rheumatic heart diseases | MNDR-E-MI-41929 |
MNDR | hsa-miR-340-5p | Oral squamous cell carcinoma | MNDR-E-MI-41930 |
MNDR | hsa-miR-340-5p | Medulloblastoma | MNDR-E-MI-41931 |
MNDR | hsa-miR-340-5p | Lymphoma | MNDR-E-MI-41932 |
MNDR | hsa-miR-340-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-41933 |
MNDR | hsa-miR-340-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-41934 |
MNDR | hsa-miR-340-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-41935 |
MNDR | hsa-miR-340-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-41936 |
MNDR | hsa-miR-340-5p | Her2-receptor positive breast cancer | MNDR-E-MI-41937 |
MNDR | hsa-miR-340-5p | Triple negative breast cancer | MNDR-E-MI-41938 |
MNDR | hsa-miR-340-5p | Breast cancer luminal | MNDR-E-MI-41939 |
MNDR | hsa-miR-340-5p | Dermatomyositis | MNDR-E-MI-41940 |
MNDR | hsa-miR-340-5p | Prostate cancer | MNDR-E-MI-41941 |
MNDR | hsa-miR-340-5p | Gastric cancer | MNDR-E-MI-41942 |
MNDR | hsa-miR-340-5p | Alzheimer disease | MNDR-E-MI-41943 |
MNDR | hsa-miR-340-5p | Dysautonomia familial | MNDR-E-MI-41944 |
MNDR | hsa-miR-340-5p | Huntington disease | MNDR-E-MI-41945 |
MNDR | hsa-miR-340-5p | Cardiovascular disease | MNDR-E-MI-41946 |
MNDR | hsa-miR-340-5p | Lung cancer | MNDR-E-MI-41947 |
MNDR | hsa-miR-340-5p | Parkinson disease | MNDR-E-MI-41948 |
MNDR | hsa-miR-340-5p | Basal-like breast cancer | MNDR-E-MI-41949 |
MNDR | hsa-miR-340-5p | Thyroid cancer | MNDR-E-MI-41950 |
MNDR | hsa-miR-340-5p | Pituitary neoplasms | MNDR-E-MI-41951 |
MNDR | hsa-miR-340-5p | Pancreatic cancer | MNDR-E-MI-41952 |
MNDR | hsa-miR-340-5p | Melanoma | MNDR-E-MI-41953 |
MNDR | hsa-miR-340-5p | Colon cancer | MNDR-E-MI-41954 |
MNDR | hsa-miR-340-5p | Colon adenocarcinoma | MNDR-E-MI-41955 |
MNDR | hsa-miR-340-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-41956 |
MNDR | hsa-miR-340-5p | Ovarian cancer | MNDR-E-MI-41957 |
MNDR | hsa-miR-340-5p | Acromegaly | MNDR-E-MI-41958 |
MNDR | hsa-miR-340-5p | Prostate adenocarcinoma | MNDR-E-MI-41959 |
MNDR | hsa-miR-340-5p | Kidney cancer | MNDR-E-MI-41960 |
MNDR | hsa-miR-340-5p | Carcinoma ductal breast | MNDR-E-MI-41961 |
MNDR | hsa-miR-340-5p | Glioblastoma | MNDR-E-MI-41962 |
MNDR | hsa-miR-340-5p | Glioma | MNDR-E-MI-41963 |
MNDR | hsa-miR-340-5p | Neurilemmoma | MNDR-E-MI-41964 |
MNDR | hsa-miR-340-5p | Central nervous system lymphoma | MNDR-E-MI-41965 |
MNDR | hsa-miR-340-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-41966 |
MNDR | hsa-miR-340-5p | Epilepsy temporal lobe | MNDR-E-MI-41967 |
MNDR | hsa-miR-340-5p | Coronary artery disease | MNDR-E-MI-41968 |
MNDR | hsa-miR-340-5p | Inclusion body myositis | MNDR-E-MI-41969 |
MNDR | hsa-miR-340-5p | Breast carcinoma | MNDR-E-MI-41970 |
MNDR | hsa-miR-340-5p | Uterine cancer | MNDR-E-MI-41971 |
MNDR | hsa-miR-340-5p | Pituitary adenoma | MNDR-E-MI-41972 |
MNDR | hsa-miR-340-5p | Lung squamous cell carcinoma | MNDR-E-MI-41973 |
MNDR | hsa-miR-340-5p | Lung adenocarcinoma | MNDR-E-MI-41974 |
MNDR | hsa-miR-340-5p | Adrenocortical carcinoma | MNDR-E-MI-41975 |
MNDR | hsa-miR-340-5p | Bladder urothelial carcinoma | MNDR-E-MI-41976 |
MNDR | hsa-miR-340-5p | Carcinoma renal cell | MNDR-E-MI-41977 |
MNDR | hsa-miR-340-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-41978 |
MNDR | hsa-miR-340-5p | Renal clear cell carcinoma | MNDR-E-MI-41979 |
MNDR | hsa-miR-340-5p | Cholangiocarcinoma | MNDR-E-MI-41980 |
MNDR | hsa-miR-340-5p | Esophageal cancer | MNDR-E-MI-41981 |
MNDR | hsa-miR-340-5p | Liver cirrhosis | MNDR-E-MI-41982 |
MNDR | hsa-miR-340-5p | Lung small cell carcinoma | MNDR-E-MI-41983 |
MNDR | hsa-miR-340-5p | Synovial sarcoma | MNDR-E-MI-41984 |
MNDR | hsa-miR-340-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-41985 |
MNDR | hsa-miR-340-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-41986 |
MNDR | hsa-miR-340-5p | Breast invasive carcinoma | MNDR-E-MI-41987 |
MNDR | hsa-miR-340-5p | Early hepatocellular carcinoma | MNDR-E-MI-41988 |
MNDR | hsa-miR-340-5p | Embryonal cancer | MNDR-E-MI-41989 |
MNDR | hsa-miR-340-5p | Lymphoblastoid | MNDR-E-MI-41990 |
MNDR | hsa-miR-340-5p | Rheumatoid arthritis | MNDR-E-MI-41991 |
MNDR | hsa-miR-340-5p | Retinoblastoma | MNDR-E-MI-41992 |
MNDR | hsa-miR-340-5p | Barrett's adenocarcinoma | MNDR-E-MI-41993 |
MNDR | hsa-miR-340-5p | Hodgkin lymphoma | MNDR-E-MI-41994 |
MNDR | hsa-miR-340-5p | Burkitt lymphoma | MNDR-E-MI-41995 |
MNDR | hsa-miR-340-5p | Tonsil cancer | MNDR-E-MI-41996 |
MNDR | hsa-miR-340-5p | Acute myeloid leukemia | MNDR-E-MI-41997 |
MNDR | hsa-miR-340-5p | Colorectal cancer | MNDR-E-MI-41998 |
MNDR | hsa-miR-340-5p | Nasopharynx carcinoma | MNDR-E-MI-41999 |
MNDR | hsa-miR-340-5p | Multiple myeloma | MNDR-E-MI-42000 |
MNDR | hsa-miR-340-5p | Nasopharyngeal cancer | MNDR-E-MI-42001 |
MNDR | hsa-miR-340-5p | Stroke lacunar | MNDR-E-MI-42002 |
MNDR | hsa-miR-340-5p | Barrett's carcinogenesis | MNDR-E-MI-42003 |
MNDR | hsa-miR-340-5p | Breast cancer her3+ negative | MNDR-E-MI-42004 |
MNDR | hsa-miR-340-5p | Low grade dysplastic nodule | MNDR-E-MI-42005 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BCL11A | Homo sapiens | RR00218496 |
TOP